This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Jan. 22, 2013 /PRNewswire/ --
The "hot cake" of the China medical devices market has attracted close eyes from EU/US companies. With a perfect blend of local and international market intelligence, Dr. Daozhi Liu from MicroPort will share details about the future of biomedical materials in the Chinese market this March at BioMed China 2013.
China's Twelfth "Five-Year Plan" has announced that, until 2015, biomedical materials such as bio-ceramics and medical metals will increase significantly in
China. Regarding biomedical materials projects, the Plan clearly points out that the State will vigorously develop medical metals and alloys such as medical polymer materials, bio-ceramics, and other related products to meet the demand for artificial organs, vascular stents and implants. This will promote the field of materials technologies, life sciences and clinical trials, as well as reduce R&D risks and production costs.
Dr. Daozhi Liu is currently Senior Vice President of Emerging Business at Shanghai MicroPort Medical (Group) Limited. He obtained his bachelor's and Ph.D. in
China in 1985 and 1991, as well as engaged in postdoctoral research at the
University of Oxford from 1993 to 1994. He returned from overseas to join MicroPort Medical (
Shanghai) Co., Ltd. as one of the core members of the early entrepreneurial team, former research center director, vice president, senior vice president, business general manager, Ortho business company legal representative and executive director. From 2003 until now, he established MicroPort's emerging business of cardiac electrophysiological medical equipment: pacemakers and orthopedic medical devices. He is also the founder and GM of Shanghai MicroPort Orthopedics Co., Ltd., a sub-branch of MicroPort in
Apart from presenting at BioMed China 2013 on
March 14 in
Shanghai, Dr. Daozhi Liu will also serve as the chairman for the full day conference and panel discussions, as well as share both his local and global key insights on biomedical materials, investment opportunities, and product value evaluation.
For more details about
BioMed China 2013 and Dr. Liu's speech, please visit the event website at
Free PowerPoint Presentations from past events can be
BioMed is hosted by UBM Conferences.